CAS: 1337532-29-2 - GSK2656157

Fórmula: C₂₃H₂₁FN₆O

InChI: InChI=1S/C23H21FN6O/c1-13-4-3-5-14(28-13)10-19(31)30-9-8-16-18(30)7-6-15(21(16)24)17-11-29(2)23-20(17)22(25)26-12-27-23/h3-7,11-12H,8-10H2,1-2H3,(H2,25,26,27)

Chave InChI: InChIKey=PRWSIEBRGXYXAJ-UHFFFAOYSA-N

SMILES: O=C(N1C=2C=CC(=C(F)C2CC1)C3=CN(C=4N=CN=C(N)C43)C)CC5=NC(=CC=C5)C

GSK2656157

CAS: 1337532-29-2

• Fórmula: C₂₃H₂₁FN₆O
• Pureza: ≥98%
• Cor e Forma: Solid
• Peso molecular: 416.4508

GSK2656157

CAS: 1337532-29-2

GSK2656157 is a highly specific and ATP-competitive PERK inhibitor (IC50: 0.9 nM) in a cell-free …

• Fórmula: C₂₃H₂₁FN₆O
• Pureza: 100%
• Cor e Forma: Solid
• Peso molecular: 416.45

GSK2656157

CAS: 1337532-29-2

Applications GSK2656157 is an ATP-competitive and highly selective inhibitor of PKR-like endoplasmic reticulum kinase (PERK) …

• Fórmula: C₂₃H₂₁FN₆O
• Cor e Forma: Neat
• Peso molecular: 416.45

5-[4-Fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl]-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine

CAS: 1337532-29-2

5-[4-Fluoro-1-[(6-methyl-2-pyridinyl)acetyl]-2,3-dihydro-1H-indol-5-yl]-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine is a melatonin analog that is under development for the treatment of human osteosarcoma …

• Fórmula: C₂₃H₂₁FN₆O
• Pureza: Min. 95%
• Peso molecular: 416.45 g/mol